The Natasha Clinical Trial: Advancing Food Allergy Treatment
Last week, we had the privilege of returning to the Southampton Clinical Research Facility to hear the latest updates from The Natasha Clinical Trial, a pioneering food allergy research study working to improve the future of food allergy and anaphylaxis treatment in the UK.
Funded by Natasha’s Foundation, the £2.7 million oral immunotherapy trial is exploring whether everyday foods containing peanut or milk, introduced gradually under close medical supervision, could become an effective and affordable NHS treatment for people living with food allergies.
The trial aims to help desensitise children and young people with peanut allergy and milk allergy, reducing the risk of severe allergic reactions and improving quality of life for families living with the daily fear of anaphylaxis.
Food allergies affect millions of people across the UK and rates of allergic disease continue to rise.
For many families, the risk of anaphylaxis, a severe and potentially life-threatening allergic reaction, impacts everyday experiences including school, eating out, travelling and social occasions. Research into food allergy treatment and prevention has never been more important.
Joining us in Southampton were some of our incredible corporate partners, including Tesco, Marks & Spencer and The Pantry, whose support is helping to fund life-changing food allergy research.
Together, we heard directly from the medical team leading the trial and learned more about how oral immunotherapy could potentially transform food allergy care and anaphylaxis management within the NHS.
Dr Mich Erlewyn-Lajeunesse, Consultant in Paediatrics and Paediatric Allergy, Immunology and Infectious Diseases, shared fascinating insights into the groundbreaking peanut and milk desensitisation work currently taking place with children and young people aged between 2 and 23 enrolled on The Natasha Clinical Trial.
The discussion prompted important conversations around food allergen labelling, allergy safety, anaphylaxis awareness and the urgent need for continued investment in food allergy research, education and treatment. One of the most powerful moments of the visit came from Amanda, the parent of a child taking part in the trial, who spoke movingly about the impact the treatment has already had on her family’s life.
For the first time, her son is now able to eat lunch alongside other children at school. The family has also started eating out at restaurants together again, something they previously did not feel safe enough to do because of the risk of allergic reactions. Her story was a powerful reminder that food allergies affect far more than diet alone. Living with food allergies and anaphylaxis can impact mental health, confidence, independence, education and everyday family life.
At Natasha’s Foundation, we believe research has the power to transform the future for people living with food allergies. The Natasha Clinical Trial is helping to advance understanding of food allergy treatment while bringing hope to families affected by severe allergies and anaphylaxis across the UK.
We would like to say a huge thank you to the entire Southampton team, including Emma Smart, for facilitating such a fascinating and inspiring visit and for the incredible work being done every day to help create a future without food allergy.